Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

被引:52
|
作者
Beaton, Melanie D. [1 ]
机构
[1] Univ Western Ontario, Dept Med, Div Gastroenterol, London, ON, Canada
关键词
Fibrosis; Hepatic steatosis; Metabolic syndrome; Treatment; RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR RISK-FACTORS; PLACEBO-CONTROLLED TRIAL; VITAMIN-E; URSODEOXYCHOLIC ACID; HEPATIC STEATOSIS; INSULIN-RESISTANCE; BARIATRIC SURGERY; IRON DEPLETION; METFORMIN;
D O I
10.1155/2012/725468
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
MD Beaton. current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. can J gastroenterol 2012;26(6):353-358. Nonalcoholic fatty liver disease is the leading cause of liver disease in western society. It is a cause of end-stage liver disease, with increased mortality secondary to cirrhosis and its complications. It is also recognized that cardiovascular disease is a significant cause of death in these patients. Significant work evaluating various treatments has been performed in recent years; however, to date, no ideal therapy exists. Lifestyle modification remains the cornerstone of management. The present article reviews the current status of various treatment modalities evaluated in nonalcoholic fatty liver disease.
引用
收藏
页码:353 / 357
页数:5
相关论文
共 50 条
  • [1] Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Hung, Chun Kit
    Bodenheimer, Henry C., Jr.
    [J]. CLINICS IN LIVER DISEASE, 2018, 22 (01) : 175 - +
  • [2] Current treatment options for nonalcoholic fatty liver disease
    Shetty, Akshay
    Syn, Wing-Kin
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2019, 35 (03) : 168 - 176
  • [3] Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Golabi, Pegah
    Bush, Haley
    Younossi, Zobair M.
    [J]. CLINICS IN LIVER DISEASE, 2017, 21 (04) : 739 - 753
  • [4] Therapeutic options for nonalcoholic fatty liver disease and steatohepatitis
    Kluwe, J
    Lohse, AW
    [J]. INTERNIST, 2005, 46 (12): : 1324 - +
  • [5] Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Yoshihisa Takahashi
    Keiichiro Sugimoto
    Hiroshi Inui
    Toshio Fukusato
    [J]. World Journal of Gastroenterology, 2015, 21 (13) : 3777 - 3785
  • [7] Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Takahashi, Yoshihisa
    Sugimoto, Keiichiro
    Inui, Hiroshi
    Fukusato, Toshio
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (13) : 3777 - 3785
  • [8] Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Brown, Gregory Thomas
    Kleiner, David E.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1080 - 1086
  • [9] Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Younossi, Zobair M.
    Loomba, Rohit
    Rinella, Mary E.
    Bugianesi, Elisabetta
    Marchesini, Giulio
    Neuschwander-Tetri, Brent A.
    Serfaty, Lawrence
    Negro, Francesco
    Caldwell, Stephen H.
    Ratziu, Vlad
    Corey, Kathleen E.
    Friedman, Scott L.
    Abdelmalek, Manal F.
    Harrison, Stephen A.
    Sanyal, Arun J.
    Lavine, Joel E.
    Mathurin, Philippe
    Charlton, Michael R.
    Chalasani, Naga P.
    Anstee, Quentin M.
    Kowdley, Kris V.
    George, Jacob
    Goodman, Zachary D.
    Lindor, Keith
    [J]. HEPATOLOGY, 2018, 68 (01) : 361 - 371
  • [10] Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Takahashi, Yoshihisa
    Fukusato, Toshio
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15539 - 15548